Decheng Capital Management III (Cayman), LLC Activity Q1 2022-Q3 2023

Q3 2023
 Value Shares↓ Weighting
ALPN NewAlpine Immune Sciences, Inc.$76,809,8986,708,28825.63%
BuyAura Biosciences, Inc.$18,243,928
+403.6%
1,163,123
+296.5%
6.09%
+436.0%
NewROIVANT SCIENCES LTD$17,049,2961,459,7005.69%
SellACELYRIN INC(NSM)$15,746,384
-51.5%
1,548,317
-0.4%
5.26%
-48.4%
LNTH NewLANTHEUS HOLDINGS INC(NMS)$9,879,778142,1963.30%
IMGN NewIMMUNOGEN INC$6,600,016415,8802.20%
SGEN NewSEAGEN INC$4,882,42023,0141.63%
BYSI NewBeyondSpring Inc.$3,966,5144,958,1431.32%
ATRC NewAtriCure Inc.$2,026,14446,2590.68%
NewPyxis Oncology, Inc (formerly Apexigen)$650,352326,8100.22%
NewGeneDx Holdings Corp.$377,118103,6040.13%
ACET SellAdicet Bio, Inc.$274,275
-77.7%
200,201
-60.4%
0.09%
-76.1%
NBSE ExitNeuBase Therapeutics, Inc.$0-50,000-0.03%
ExitGeneDx Holdings Corp.$0-103,604-0.19%
ExitApexigen, Inc.$0-1,894,551-0.26%
ExitAtriCure Inc.$0-46,259-0.72%
SGEN ExitSeagen Inc.$0-23,014-1.39%
ExitBeyondSpring Inc.$0-4,958,143-1.84%
ExitROIVANT SCIENCES LTD$0-1,459,700-4.62%
ALPPRNCL ExitAlpine Immune Sciences, Inc.$0-6,708,288-21.63%
Q2 2023
 Value Shares↓ Weighting
ALPPRNCL NewAlpine Immune Sciences, Inc.$68,961,2016,708,28821.63%
ZNTL NewZentalis Pharmaceuticals Inc.$59,229,2362,099,58318.58%
NewACELYRIN INC(NSM)$32,487,3151,554,41710.19%
TXG New10x Genomics, Inc.$20,077,495359,5546.30%
PACB NewPacific Biosciences of California, Inc.$19,469,4981,463,8726.11%
RCUS NewArcus BioSciences, Inc.$17,665,435869,7905.54%
ILMN NewIllumnia, Inc.$15,160,25480,8594.76%
NewROIVANT SCIENCES LTD$14,713,7761,459,7004.62%
PHAT NewPHATHOM PHARMACEUTICALS INC$12,172,000850,0003.82%
ARGX NewArgenx SE$10,689,90427,4293.35%
HZNP NewHorizon Therapeutics PLC$8,114,86578,9002.54%
TERN NewTerns Pharmaceuticals, Inc.$6,249,994714,2851.96%
NewBeyondSpring Inc.$5,850,6094,958,1431.84%
SGEN NewSeagen Inc.$4,429,27423,0141.39%
NewAura Biosciences, Inc.$3,622,663293,3331.14%
NewAadi Bioscience, Inc.$3,600,090526,3291.13%
EQ NewEquillium Inc.$3,335,4814,447,3081.05%
NewCue Health Inc.$3,322,9368,980,9091.04%
MRSN NewMersana Therapeutics, Inc.$2,975,042904,2680.93%
NewAtriCure Inc.$2,283,34446,2590.72%
SCYX NewScynexis Inc.$1,638,887555,5550.51%
ACET NewAdicet Bio, Inc.$1,228,773505,6680.38%
NewApexigen, Inc.$814,2781,894,5510.26%
NewGeneDx Holdings Corp.$617,479103,6040.19%
NBSE NewNeuBase Therapeutics, Inc.$92,50050,0000.03%
Q4 2022
 Value Shares↓ Weighting
NBSE ExitNeuBase Therapeutics, Inc.$0-1,000,000-0.14%
NAUT ExitNautilus Biotechnology, Inc.$0-300,000-0.23%
ExitOwlet, Inc.$0-898,400-0.35%
SCYX ExitScynexis Inc.$0-555,555-0.48%
ExitAtriCure Inc.$0-46,259-0.66%
ARGX ExitArgenx SE$0-5,529-0.71%
ExitSema4 Holings Corp.$0-3,418,929-1.09%
SGEN ExitSeagen Inc.$0-23,014-1.14%
ExitAura Biosciences, Inc.$0-210,000-1.38%
TERN ExitTerns Pharmaceuticals, Inc.$0-714,285-1.52%
HZNP ExitHorizon Therapeutics PLC$0-78,900-1.77%
BYSI ExitBeyondSpring Inc.$0-4,958,143-1.78%
ExitApexigen, Inc.$0-1,894,551-1.85%
MRSN ExitMersana Therapeutics, Inc.$0-904,268-2.22%
ExitAadi Bioscience, Inc.$0-526,329-2.70%
ACET ExitAdicet Bio, Inc.$0-580,000-2.99%
PACB ExitPacific Biosciences of California, Inc.$0-1,463,872-3.08%
EQ ExitEquillium Inc.$0-4,447,308-3.58%
TXG Exit10x Genomics, Inc.$0-359,554-3.71%
ALBO ExitAlbireo Pharma, Inc.$0-623,342-4.38%
RXDX ExitPrometheus Biosciences, Inc.$0-250,000-5.35%
RCUS ExitArcus BioSciences, Inc.$0-869,790-8.25%
ILMN ExitIllumnia, Inc.$0-130,138-9.00%
ExitCue Health Inc.$0-8,980,909-9.80%
ZNTL ExitZentalis Pharmaceuticals Inc.$0-1,824,583-14.33%
ALPN ExitAlpine Immune Sciences, Inc.$0-6,708,288-17.51%
Q3 2022
 Value Shares↓ Weighting
ALPN BuyAlpine Immune Sciences, Inc.$48,300,000
+20.5%
6,708,288
+42.5%
17.51%
+15.3%
ILMN SellIllumnia, Inc.$24,829,000
-12.7%
130,138
-15.6%
9.00%
-16.5%
ALBO BuyAlbireo Pharma, Inc.$12,068,000
+17.2%
623,342
+20.3%
4.38%
+12.1%
TXG Buy10x Genomics, Inc.$10,240,000
-25.6%
359,554
+18.3%
3.71%
-28.8%
NewApexigen, Inc.$5,115,0001,894,5511.85%
BYSI BuyBeyondSpring Inc.$4,909,000
-31.2%
4,958,143
+0.0%
1.78%
-34.2%
HZNP BuyHorizon Therapeutics PLC$4,883,000
+10.5%
78,900
+42.4%
1.77%
+5.6%
SGEN NewSeagen Inc.$3,149,00023,0141.14%
ARGX NewArgenx SE$1,952,0005,5290.71%
OMIC ExitSingular Genomics Systems, Inc.$0-20,000-0.03%
MASS Exit908 Devices Inc.$0-20,000-0.16%
Q2 2022
 Value Shares↓ Weighting
ZNTL NewZentalis Pharmaceuticals Inc.$51,271,0001,824,58319.44%
ALPN NewAlpine Immune Sciences, Inc.$40,068,0004,708,28815.19%
NewCue Health Inc.$28,739,0008,980,90910.90%
ILMN NewIllumnia, Inc.$28,435,000154,23810.78%
RCUS NewArcus BioSciences, Inc.$22,040,000869,7908.36%
TXG New10x Genomics, Inc.$13,755,000303,9845.22%
ALBO NewAlbireo Pharma, Inc.$10,294,000518,3423.90%
EQ NewEquillium Inc.$9,073,0004,447,3083.44%
ACET NewAdicet Bio, Inc.$8,468,000580,0003.21%
BYSI NewBeyondSpring Inc.$7,140,0004,958,1422.71%
RXDX NewPrometheus Biosciences, Inc.$7,058,000250,0002.68%
NewAadi Bioscience, Inc.$6,484,000526,3292.46%
PACB NewPacific Biosciences of California, Inc.$6,470,0001,463,8722.45%
HZNP NewHorizon Therapeutics PLC$4,419,00055,4001.68%
NewSema4 Holings Corp.$4,308,0003,418,9291.63%
MRSN NewMersana Therapeutics, Inc.$4,178,000904,2681.58%
NewAura Biosciences, Inc.$2,976,000210,0001.13%
NewAtriCure Inc.$1,890,00046,2590.72%
TERN NewTerns Pharmaceuticals, Inc.$1,771,000714,2850.67%
NewOwlet, Inc.$1,527,000898,4000.58%
NBSE NewNeuBase Therapeutics, Inc.$1,050,0001,000,0000.40%
SCYX NewScynexis Inc.$1,033,000555,5550.39%
NAUT NewNautilus Biotechnology, Inc.$807,000300,0000.31%
MASS New908 Devices Inc.$412,00020,0000.16%
OMIC NewSingular Genomics Systems, Inc.$76,00020,0000.03%

Export Decheng Capital Management III (Cayman), LLC's holdings